Astrana Health (NASDAQ:ASTH) Updates FY24 Earnings Guidance

Astrana Health (NASDAQ:ASTH) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.06-1.19 for the period, compared to the consensus estimate of $1.23. The company issued revenue guidance of $1.95-2.03 billion, compared to the consensus revenue estimate of $1.84 billion.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on ASTH shares. BTIG Research boosted their price objective on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Robert W. Baird boosted their price target on shares of Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a research note on Thursday, August 15th. TD Cowen assumed coverage on shares of Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price objective for the company. KeyCorp started coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Stifel Nicolaus increased their target price on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $62.00.

Astrana Health Stock Down 0.7 %

Shares of ASTH stock traded down $0.41 during trading hours on Thursday, reaching $59.08. 279,308 shares of the stock were exchanged, compared to its average volume of 197,387. The business’s fifty day moving average is $55.30 and its two-hundred day moving average is $47.32. The firm has a market capitalization of $2.90 billion, a P/E ratio of 41.31, a P/E/G ratio of 2.08 and a beta of 1.24. Astrana Health has a 12-month low of $29.63 and a 12-month high of $63.20. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.84 and a quick ratio of 1.84.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.39 by $0.01. The company had revenue of $486.30 million during the quarter, compared to analysts’ expectations of $440.68 million. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The firm’s revenue was up 39.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.28 EPS. As a group, research analysts expect that Astrana Health will post 1.31 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.